Pyrazole compounds and uses related thereto

Details for Australian Patent Application No. 2005228856 (hide)

Owner Amgen Inc.

Inventors Goto, Hiroyuki; Kakutani, Makoto; Tu, Hua; Powers, Jay P.; Yata, Shinji; Ohe, Yasuhiro; Nishiu, Jun

Agent Knightsbridge Patent Attorneys

Pub. Number AU-B-2005228856

PCT Pub. Number WO2005/095350

Priority 60/556,013 23.03.04 US; 11/084,734 18.03.05 US

Filing date 21 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 4 February 2010

International Classifications

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

C07D 211/04 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 263/04 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/08 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/095350 Priority application(s): WO2005/095350

4 February 2010 Application Accepted

  Published as AU-B-2005228856

18 March 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 18 Jan 2010. Address for service in Australia - Knightsbridge Patent Attorneys Level 14 200 Queen Street MELBOURNE VIC 3000

8 July 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 15 Jan 2010 2005291729 2D2C, Inc. The nature of the amendment is as shown in the statement(s) filed 02 Feb 2010 and 24 Feb 2010

8 July 2010 Corrigenda

  Amendments - Application for Amendments Under the name Amgen Inc., Application No. 2005228856, correct the date the statement(s) was filed from 18 Jan 2010 to 15 Jan 2010

15 July 2010 Standard Patent Sealed

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005228859-Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl)ure ido]-phenyl}-ethyl)-carbamic acid2-cyano-1-ethyl-ethyl ester

2005228855-Particle containing solid surface material